Henriette Kühle1,2,3
Steven K. S. Cho1,4,5
Nathaniel Barber1
Datta Singh Goolaub6
Jack R. T. Darby5
Janna L. Morrison4,5,7
Christoph Haller3
Liqun Sun1,6*
Mike Seed1,4,6,7,8*
- 1Division of Cardiology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
- 2Department of Cardiac and Thoracic Surgery, University Hospital Magdeburg, Otto von Guericke University Magdeburg, Magdeburg, Germany
- 3Division of Cardiac Surgery, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
- 4Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada
- 5Early Origins of Adult Health Research Group, University of South Australia, Adelaide, SA, Australia
- 6Translational Medicine Program, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
- 7Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
- 8Department of Diagnostic Imaging, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
Over recent decades, a variety of advanced imaging techniques for assessing cardiovascular physiology and cardiac function in adults and children have been applied in the fetus. In many cases, technical development has been required to allow feasibility in the fetus, while an appreciation of the unique physiology of the fetal circulation is required for proper interpretation of the findings. This review will focus on recent advances in fetal echocardiography and cardiovascular magnetic resonance (CMR), providing examples of their application in research and clinical settings. We will also consider future directions for these technologies, including their ongoing technical development and potential clinical value.
Introduction
As we increasingly regard the unborn fetus as a patient and develop improved prenatal diagnosis and treatment of a range of fetal conditions, we require more sophisticated approaches to assessing fetal wellbeing. There is no better example of the evolution of prenatal diagnosis and therapy than our imaging approach to the fetal heart and cardiovascular system. The prenatal diagnosis of congenital heart disease has transformed the perinatal management of these common birth defects, resulting in improved outcomes and offering families an opportunity to make informed choices about a range of management options. The transplacental treatment of fetal arrhythmias represents one of the earliest and most widely used forms of fetal therapy. With the advent of minimally invasive catheter interventions for severe forms of congenital heart disease, we have learned that in selected cases it may be possible to modify the natural history of congenital heart disease, thereby avoiding the need for single ventricle palliation while improving fetal development. The advent of increasingly sophisticated approaches to fetal cardiac imaging has played an essential role in this story, with advances in the assessment of fetal cardiac function occurring in tandem with new treatments (1, 2). For example, abnormalities of myocardial loading and performance manifesting as cardiac enlargement, reduced contractility or hydrops may be observed in the setting of congenital heart lesions such as Ebstein's anomaly or critical aortic stenosis as well as other fetal cardiac conditions such as cardiomyopathies and fetal arrhythmias (3–5). The severity of the cardiac compromise in these settings may determine the indication for fetal treatment and serve as a marker of response to therapy. Similarly, the detection of subtle abnormalities of cardiovascular physiology or heart function may provide clues to the presence of extra-cardiac pathologies, including fetal growth restriction (FGR), fetal anemia and twin-to-twin-transfusion syndrome (TTTS).
Echocardiography is a widely available and non-invasive technique that is used to identify structural heart disease and predict prognosis (6, 7). Through technical advances and growing expertise, fetal echocardiography, which was first described in 1964, is now increasingly integrated into routine obstetric ultrasound (8–10). Ultrasound provides excellent contrast between the myocardium and blood pool with high spatial and temporal resolution, allowing exquisite visualization of cardiac anatomy and function. Conventional 2-dimensional (2D) echocardiography is used to visualize myocardial deformation and measure fractional shortening, obtained with standard grey-scale imaging or M-mode and converted to ejection fraction using the cube method or Teichholz formula. By contouring the endocardial border in systole and diastole from 2D echo images, more accurate measures of ejection fraction can be obtained using Simpson's method. Ventricular function can also be further quantified in utero using M-mode echocardiography. A variety of Doppler techniques further enhance the assessment of cardiac physiology, as well as providing information about vessel tone and resistance in the various fetal vascular beds. Color Doppler allows direct visualization of the flow of blood through the heart and vessels, while pulsed Doppler provides peak and mean velocities across valves, vessels, and cardiac chambers, as well as the characterization of flow patterns throughout the cardiac cycle. Thus, left ventricular stroke volume can be calculated as the product of left ventricular outflow tract area and mean flow velocity. Systemic and pulmonary venous flow patterns and inflow velocity profiles across the atrioventricular valves provide information about diastolic function. Systolic and diastolic function can be further interrogated using Tissue Doppler Imaging (TDI), while three-dimensional (3D) or four-dimensional (4D) echocardiographic techniques yield alternative approaches to measuring chamber volumes, stroke volume and ejection fraction. Speckle tracking provides an approach to regional and global strain and strain rate imaging. However, accurate prenatal diagnosis by fetal echocardiography depends on the skill and experience of the operator, particularly in the setting of complex cardiac anatomy. The correct interpretation of the imaging may be challenging when ultrasound imaging is hampered by poor visualization of the fetal heart resulting from adverse maternal body habitus, fetal positioning or oligohydramnios. With advancing gestation, image quality may also be affected by the progressive calcification of the fetal ribs and spine (11) and by the increasing distance between the ultrasound probe and the fetal heart (12). At younger gestations, vigorous fetal motion may compromise fetal cardiac imaging, while difficulties in obtaining certain cardiac views may be further aggravated by the more horizontal orientation of the long heart axis due to a relatively large fetal liver (13, 14). The fetal electrocardiogram (ECG) is not readily available for advanced techniques that require synchronization of image collection to the cardiac cycle, which has led to the implementation of alternative gating methods i.e., via anatomic M-mode, or mitral movement (12, 15–17).
The application of fetal Cardiovascular Magnetic Resonance has been slower than other fetal Magnetic Resonance Imaging (MRI) techniques, which may partly reflect the challenges associated with obtaining diagnostic cardiac imaging of appropriate quality in the fetus with MRI. Cardiac MRI provides accurate measurements of right and left ventricular end-diastolic and end-systolic volumes, and therefore stroke volume and ejection fraction, typically through the segmentation of a stack of short axis cine images through the ventricular mass. Thus, fetal CMR typically generates thicker imaging planes than ultrasonographic techniques (6), and usually requires significant attention to postprocessing, but can result in improved image quality when ultrasound imaging is hampered by maternal obesity, oligohydramnios, or rib calcification, especially in the later stages of pregnancy (1, 18, 19). Fetal CMR is challenged by the lack of an ECG signal for cardiac gating, the high fetal heart rate and, most importantly, by frequent fetal body motion. Thus, a series of technical adaptations have been required to make fetal CMR feasible, including several alternative gating methods including self-gating (20–25), retrospective metric optimized gating (26–29), and CTG- or Doppler ultrasound cardiac gating (30–39) and accelerated acquisition strategies employing under-sampling methods and motion correction. As a result of the innate tradeoff between scan time and signal-to-noise ratio (SNR), fetal CMR has significantly lower spatial and temporal resolution than ultrasound. Cine phase contrast MRI provides information about ventricular function by providing accurate measurements of vessel flow. Myocardial tagging and feature tracking are MRI techniques for measuring strain and strain rate. A sensitive marker of LV function that is available by MRI is LV torsion, whereby apical and basal segments rotate in opposite directions. Other non-invasive techniques for assessing ventricular function such as nuclear medicine and computed tomography typically require ionizing radiation and the injection of contrast agents, making them unsuitable for fetal imaging. Contraindications such as claustrophobia can limit the application of fetal CMR, which may also be poorly tolerated due to the requirement for immobilization. This issue is particularly relevant in the late gestation (40, 41). However, fetal CMR is gaining in popularity as an adjunct to fetal echocardiography and has been recommended by the American Heart Association in the setting of complex viscero-sital cardiac abnormalities and for its evolving role in assessing fetal cardiovascular physiology (1, 34, 37, 41–43). Some traditional strengths of CMR in postnatal heart disease include the delineation of vascular anatomy by angiography, as well as accurate ventricular volumetry for assessing cardiac chamber sizes and function, and quantifying vessel flow and valvar regurgitation and myocardial tissue characterization. While administering gadolinium contrast agents is contraindicated in pregnant patients, a combination of late gadolinium enhancement and cardiac cine imaging has been used to evaluate the biology of myocardial infarctions and ventricular function in preclinical fetal and postnatal sheep studies (44, 45). A combination of vessel flow and magnetic resonance oximetry has also been applied in sheep to assess the distribution of blood flow and oxygen transport across the fetal circulation, and as an approach to comprehensively quantifying the placental oxygen transfer (31, 46–51). Fetal CMR has been used in human pregnancies to study the effect of congenital cardiac malformations on fetal cardiovascular physiology, particularly through the implementation of cine phase contrast for quantifying vessel flow and relaxometry for characterizing vessel oxygen saturation and hematocrit, techniques that have also been applied in the setting of fetal growth restriction and anemia (19, 25, 29, 33, 37, 38, 50, 52–64).
For this review, authors specialized in different fields worked together to review literature on advancements in the technology to assess fetal heart function focusing on the most recent findings and referring to their first implementations and development when applicable.
Approaches to assessing cardiac function
Fetal echocardiography
Several guidelines providing details regarding the correct acquisition and interpretation of fetal echocardiographic functional parameters have been published (5, 65–73). Additional resources detail a range of well-established techniques for assessing fetal cardiac function by echo (3, 5, 6, 18, 65, 74–77). Summaries of some of the more popular techniques for assessing ventricular function by fetal echo are provided below. Most quantitative fetal echocardiographic techniques for assessing myocardial function have similar limitations in the fetus as they do in the postnatal heart, which includes finite reproducibility resulting from challenges in obtaining correct alignment (78). In common with most non-invasive methods for assessing myocardial function, standard echocardiographic parameters such as ejection fraction or ventricular fractional area change are representative of the load-dependent pumping function of the ventricle, rather than cardiomyocyte contractility or changing cavity pressure in the fetal heart (79, 80). Evaluation of strain rate, on the other hand, mainly reflects maturational changes in the myocardium while being relatively independent of loading conditions (81). Scoring systems like the fetal cardiovascular profile score (CVPS), shown in Figure 1, which incorporates cardiac functional indices with other imaging and Doppler findings including extracardiac vessels, as well as more specific measures of cardiac cycle intervals such as the myocardial performance index and Tei index have been established in the fetus (3, 6, 18, 82–89). Figure 2 shows an example of the application of 2D echocardiography and Doppler to calculate the CVPS in a fetus with Ebstein's anomaly with severe displacement of the tricuspid valve with good LV function.
Figure 1. Cardiovascular profile score (CVPS) to assess fetal heart function, adapted from (89).
Figure 2. The assessment of fetal cardiac function and cardiovascular profile in Ebstein anomaly showing severe cardiomegaly (cardiothoracic ratio: 0.69) with severely dilated right atrium and right ventricle and compressed lungs and mild to moderately reduced RV function, fetal hydrops with a small pericardial effusion, significant ascites and scalp edema. The Dopplers reveal intermittent a-wave reversal in the ductus venosus and umbilical vein notching suggestive of elevated cardiac filling pressures and intermittently absent diastolic flow in the umbilical artery consistent with a systemic steal. (A) Four chamber view suggesting severe cardiomegaly (cardiothoracic ratio: 0.69) and dilated right heart. (B) Color Doppler showing tricuspid regurgitation. (C) Doppler of tricuspid valve showing biphasic flow with high velocity. (D) Intermittently absent diastolic flow in the umbilical artery. (E) Umbilical vein notching. (F) The intermittent a-wave reversal in the DV.
2D echocardiography and M-mode
Two-dimensional echocardiographic still-frames and cines include the standard views (abdominal situs view, four-chamber view, left ventricular outflow tract view, right ventricular outflow tract, and three-vessel view). Qualitative impairments of systolic function are typically graded as mild, moderate or severe, and frequently combined with measures of cardiothoracic ratio and other imaging findings such as vessel Dopplers, the presence or absence of hydrops and non-specific signs of fetal wellbeing such as amniotic fluid volume, and fetal growth and activity to provide an overall assessment of fetal cardiac function (3, 90). This approach, being fast and easy to execute, is frequently used as the single diagnostic method (71) despite its potential limitations. When video sequences of four-chamber view or short axis are saved, those loops can be post-processed, for example using the newer speckle tracking approach discussed below. M-mode, which captures dynamic variation in structures imaged along a single line of a 2D image, provides an approach to quantitatively analyzing systolic function, assuming the correct alignment is achieved and when standard and homogenous ventricular volumetry is present (6, 18, 68, 74, 91, 92). Stroke volume can be estimated by applying Simpson's rule, which implies an ellipsoid ventricular shape (6), while longitudinal ventricular function can be assessed based on atrioventricular plane displacement (77). Figure 3 gives an example of basic assessment of the heart by 2D echocardiography and M-Mode in a patient with a family history of hypertrophic cardiomyopathy and aortic atresia illustrating the information obtained by these techniques.
Figure 3. 2D and M-mode assessment of left ventricular function in (A) a fetus with a family history of hypertrophic cardiomyopathy at 30 + 1 weeks and (B) a fetus with severe aortic stenosis and left ventricular endocardial fibroelastosis at 26 + 1 week.
Doppler and tissue Doppler
Doppler techniques are routinely used in fetal medicine to measure circulatory parameters of placental function and cardiovascular physiology (93, 94). Veins continuous with the right ventricle (ductus venosus, inferior vena cava, hepatic veins) exhibit typical waveforms (6) that vary with normal maturational changes in hemodynamics occurring through gestation. By contrast, the umbilical vein flow is constant from the end of the first trimester onward (18). Altered velocity profile patterns in these veins can depict changes in fetal condition or myocardial dysfunction and serve as predictive parameters for fetal outcomes (95). Doppler is dependent on the angle of insonation and relies on the direction of blood flow being parallel to the beam for reliable measurement of velocity (6). Acquiring Doppler spectra with correct alignment can be challenging in the fetus, although mathematical angle corrections are possible (96). In fetal hypoxia, deep or reversed a-waves in the ductus venosus and pulsatile flow in the umbilical vein reflect cardiac dysfunction (64, 97–99) and correlate with poor fetal outcomes (18, 85, 100). Similarly, middle cerebral artery pulsatility is reduced due to cerebral vasodilation or “brain-sparing physiology” in the setting of fetal hypoxemia secondary to placental insufficiency or other causes (82, 93, 101–103). Pulsed Doppler is also used to assess flow patterns within the cardiac chambers and across valves (104). Atrioventricular valve flow patterns can help to evaluate diastolic function by characterizing the biphasic E and A waves, their ratio, deceleration time, isovolumetric relaxation time and change with gestation (6, 14), with normal E/A ratios usually <1 in the developing fetus (18). In congenital heart disease (CHD), abnormal and non-biphasic patterns can reflect pathologies like aortic stenosis, while reduced ratios may be seen in FGR and hydrops, although a high fetal heart rate can lead to the fusion of E and A waves (18, 81). Tricuspid inflow, hepatic vein flow, lateral tricuspid annulus TDI, and collapsibility of the inferior vena cava help to define diastolic function (71), while the ejection force in the outflow tracts reflects systolic performance (6). Stroke volume and combined ventricular output (CVO) can be calculated based on the diameters of the ventricular outflow tracts, the velocity time integral across the valve and heart rate. The outputs of the ventricles can be indexed to fetal weight using an estimate based on measurements of head size, abdominal circumference, and femur length (3). Color Doppler gives a visual overview of blood flow directions and mean velocities, which can be particularly helpful for the evaluation of cardiac symmetry and the direction and continuity of fetal shunts and valves. Color Doppler is therefore useful in the detection of congenital cardiac defects and is essential for visualizing valve regurgitation, which is an important cause of heart failure in the fetus (5, 75, 82, 105, 106). Color Doppler is also used to guide the placement of the sample volume for spectral Doppler measurements (5, 68, 107). Tissue Doppler Imaging is used to quantitatively analyse segmental wall motion and individual point changes in myocardial velocity (18). This allows the evaluation of motion- and time-related events that provide information about systolic and diastolic cardiac function (1). Valve motion of the mitral or tricuspid valve annulus relative to the relatively stable apex assesses longitudinal contractility (18, 71) typically presenting as S', E' and A' waves by pulsed wave (PW) TDI, representing systolic, early diastolic and late diastolic annular peak velocities (3, 71). However, the combination of the relatively small amount of fetal myocardial tissue and large voxel volume may result in low reproducibility, and the use of fetal TDI has mainly been limited to research settings (1). Related techniques like Color TDI and PW Doppler exhibit inconsistent results with respect to velocities in the adult heart (10%–20% higher by TDI) (78). Nevertheless, TDI relies less on image quality or border detection and has higher frame rates than 2D echocardiography or MRI (96).
3D/4D echocardiography
The extension of two-dimensional imaging into real-time or reconstructed volume data sets as 3D or gated 4D sequences can be used to reproduce an unlimited number of adjustable standard 2D views. This approach to fetal cardiac imaging achieves reasonable temporal resolution combined with a relatively low acquisition time to provide a more detailed assessment of geometric and morphological changes, including stroke volume, ejection fraction and cardiac output for both ventricles (1, 6, 18, 24, 108, 109). While cheaper and more widely available than MRI (71), ultrasound 3D and 4D cardiac imaging requires dedicated transducers and expertise (1), may underestimate volumes (25, 71) and lacks temporal and spatial resolution compared with 2D imaging, especially with ungated techniques (1). Spatiotemporal image correlation (STIC) allows a volume reconstruction of a cardiac cycle by extracting temporal information from 2D images combined with other standard echocardiographic techniques and leads to a more coherent 4D reconstruction. However, this approach to cardiac cycle reconstruction requires a relatively long acquisition time that may result in motion degraded datasets (1, 5, 6). Newer iSTIC (intelligent STIC) acquisition algorithms can generate higher resolution images faster to reduce artifacts (109). Indeed, several studies have concluded that these methods are a useful addition to standard 2D images (110).
Speckle tracking echocardiography
Strain is defined as the grade of tissue deformation that corresponds to the change in length or thickness in response to an applied force, while strain rate is the velocity of this deformation (111). Speckles generated by ultrasound backscatter and interference form natural patterns within the myocardium, a kernel is their corresponding functional unit. The units, distance, and velocity among each other reflect strain and strain rate. Negative strain reflects the shortening that typically occurs in systole, while positive values depict diastolic lengthening (3, 12). The results are usually presented as velocity vectors within the image and as curves for strain and strain rate across the cardiac cycle. Additionally, peak values and the time and acceleration needed to reach those can be calculated. Speckle tracking and velocity vector imaging (VVI) provide an approach to semi-automatically perform post-processing of 2D four-chamber or short axis images acquired in standard examinations. This approach tracks the endocardial border of the ventricles, making automatic adjustments of the contours and providing calculations of strain, strain rate and velocity (12, 96). Concerningly, no imaging standard for this approach has yet been established (113, 114), which reflects both the differences in the software packages available and the challenge of achieving standardized imaging planes in the fetus (113–115). Examination consistency is the key to reducing variability and confounding effects (114, 116). While 2D strain and VVI use the same speckle tracking approach, the manually selected region for 2D strain usually includes the whole myocardial wall as opposed to the narrower myocardial layer tracked in VVI through algorithm border detection (111). The myocardium is usually divided into at least six segments (basal, apical, middle left and right) with possible expansion to 16- or 17-segment models for better localization of potentially restricted segments (91). Several strain types can be measured including longitudinal shortening, radial thickening, and circumferential shortening (111). In the small fetal heart, longitudinal, global strain measurements seem to be the most accurate and sensitive to pathology (14). Multiple segmental measurements do not significantly differ from global ones (96), and a globally assessed longitudinal measurement reduces the overall error by avoiding inconsistencies with the definition of exact boundaries (117). Additionally, global measurements are less affected by local noise (118), and segmental dysfunctions are less likely in the fetus compared to the adult population (111). By contrast with movement, strain and especially Lagrangian strain [strain relative to initial length, i.e., a single reference length field (12)] and its velocity (strain rate) are not dependent on adjacent regions, making them more accurate than simple velocity measurements (71, 77, 96, 119, 120). Strain measurements, influenced by extrinsic loading and intrinsic contractile force (14, 71), consider the contractility of the cardiomyocytes and changes with cardiac cavity pressure (79). Longitudinal strain and strain rate seem to reflect the fetal right ventricular dominance with strain and strain rate values between 1 and 1.5 times higher in the right compared to the left ventricle (121). Myocardial fiber orientation in the fetus with a continuous 3D meshwork in the LV contributing to systolic deformation and ventricular ejection (122) compared to the longitudinally aligned myocardium in the RV (71) limits the accuracy of reflecting longitudinal or circumferential movements in each ventricle (123). The prominent trabeculation of the RV can make border definition challenging for structures like the right atrial appendage, crista terminalis, fossa ovalis (112) or discontinued regions such as the opening of pulmonary veins into the LA and tissue elasticity can affect accuracy (14). A high contrast between the endocardium with chamber cavity and precise tracking of the walls are necessary to not underestimate strain and strain rate values (124).
Since ECG gating is not readily available from the fetus, alternative gating techniques such as using the R-wave or M-mode to define the end-diastolic to end-systolic cycle help to keep the stored images at high reliability and frame rate (78). Beat-to-beat analysis is possible even in arrhythmia (12), and offline postprocessing is more robust and reproducible (7, 125). The large number of software packages, albeit with some variability in measurements (113, 126–128), and the availability of ultrasound machines may increase the usage of strain imaging while simultaneously decreasing comparability (122), especially since only the measurement of global longitudinal strain is available in all softwares (91, 129). Nonetheless, several studies have reported better inter- and intra-observer variability than standard techniques (7, 125, 130). Training in the acquisition and analyses of high-resolution echocardiographic images (125) is necessary to establish this method successfully (76). With more experience, 2D speckle tracking imaging may be feasible and reproducible in the fetal heart (4, 7, 113, 118). For example, strain imaging has been shown to detect functional abnormalities in human fetuses with cardiac disease (111) and hypoxemic sheep (93). Figure 4 shows cardiac strain imaging in a preclinical pig model of the artificial placenta (131, 132). In Figure 5 we applied strain analysis in the two human fetuses with CHD shown in Figure 2 and revealed changes in strain associated with reductions in combined ventricular output.
Figure 4. 2D strain in LV and M-mode analysis from 4CV in an artificial placenta piglet model by echocardiography obtained using a voluson S6 (GE healthcare ultrasound, WI, USA) and post-processing software by TOMTEC (TOMTEC imaging systems GmbH, Germany). A gated M-Mode loop of two cardiac cycles was generated using a four-chamber cine loop, allowing for automatic LV strain analysis. Compared to the original M-mode measurements, the post-processing technique seems feasible and generated similar values for ejection fraction, with good repeatability between serial measurements. (A) Strain Analysis. (B) M-mode. (C) Segmental endocardial strain. (D) Segmental endocardial strain rate. Superimposed anatomical M-Mode behind graphs, endocardial border detection.
Figure 5. 2D strain on LV analysis from 4 chamber view in (A) a patient with a family history of hypertrophic cardiomyopathy resulting in increased CVO and overall elevated strain measurements and (B) a patient with aortic stenosis resulting in reduced CVO and deviating strain measurements between the ventricular septum due to indirect movement of the hypoplastic and dysfunctional LV by the adjacent RV.
Following the first description of strain imaging for cardiac assessment by Uematsu et al. in 1995 (133) and Heimdal et al. in 1998 (134), Harada et al. were the first to report the feasibility of measuring strain in fetal hearts in 1999 (135). In postnatal subjects, Nesser et al. (136) attempted to use 3D echocardiographic imaging to generate better correlations with MRI measurements than 2D strain, which seemed to underestimate LV volumes, while Enzensberger et al. (137) showed the feasibility of 3D strain imaging. However, the small size of the fetal heart compared with adults may alter the pixel-to-myocardial value ratio, making it harder for a speckle to be tracked accurately while over-smoothing resulting from lower spatial resolution is possible (122). Furthermore, exclusion of the cardiac apex can lead to chamber foreshortening (117), resulting in an overestimation of movement between the false apex and the heart's base (92, 111). Some softwares may be unsuitable for assessing a small fetal heart, whereby the smallest available segment might already be thicker than the whole myocardial wall (7). There is currently no consensus about the optimal frame rate for strain imaging, which may be particularly relevant in the setting of high fetal heart rates. While the highest possible frame rates are recommended (i.e., above 60–100 fps) (17, 111, 123, 125, 126), accurate results have been reported with frame rates as low as 30 fps (113). Stable frame rates throughout examinations can improve comparability (114). Several studies have tracked the influence of gestational age on strain measurements with highly varying results from no correlation (13, 80, 138, 139) to decreasing values with maturation (13, 111, 117, 127, 130). This variation in findings raises the possibility that the results of fetal strain imaging are likely to be dependent on equipment and software, as well as the study population and approach, emphasizing the importance of establishing standardized techniques. In addition to healthy pregnancies, strain has been measured in fetuses that are small for gestational age, and with FGR and ventricular septal defect (81, 140). Fetal echocardiographic strain imaging has also been reported as an approach to assessing disease progression and determining the optimal timing of intervention in fetuses with maternal diabetes and pregnancies complicated by TTTS and fetal growth restriction (111).
Fetal cardiovascular magnetic resonance imaging
Fetal MRI was initially developed for non-cardiovascular applications, which partly reflects the technical challenges associated with applying cardiovascular MRI in the fetus (150). However, in animal models these challenges can be overcome with anesthesia (151) which limits fetal body motion, and catheterization of fetal vessels, which allows for the detection of a blood pressure waveform that can be used for cardiac triggering (31, 50, 152). Thus, the cardiovascular magnetic resonance techniques that are routinely used for the non-invasive assessment of ventricular function in postnatal patients have been applied in fetal sheep to quantify myocardial mass and right and left ventricular volumes and ejection fractions. Fetal CMR with late gadolinium enhancement has also been used to detect cardiac damage in an experimental model of infarction (44, 153) and to measure vessel flow and oxygen content (48, 154) in an attempt to emulate the invasive hemodynamic measurements made in fetal sheep that have defined our modern understanding of normal fetal circulatory physiology. Similarly, through the development of alternatives to conventional ECG gating, accelerated imaging and motion correction algorithms, this combination of vessel flow and oximetry measurements has been applied in human fetuses to explore the normal circulation (154) as well as the impact of congenital heart malformations and vasoactive agents (48) on fetal circulatory physiology (37, 43). The potential role of fetal CMR as an adjunct to ultrasound has also been investigated in the setting of severe fetal hemodynamic compromise, for example in patients undergoing fetal cardiac interventions (37, 56). Fetal MRI provides information about other organ systems that may be affected by heart disease, including the lungs and brain, which can be incorporated into management planning (155). However, significant limitations of fetal CMR, including its inferior spatial and temporal resolution compared with ultrasound, its cost, and the requirement for considerable post-processing technology and time have limited the clinical implementation of fetal CMR (156). In addition, the FDA recommends limiting the use of MRI in the first trimester due to safety concerns about the impact of strong magnetic fields on embryogenesis. Accordingly, clinical trials and clinical applications of fetal CMR have typically been limited to second and third-trimester examinations (40).
Cine phase contrast MRI for the assessment of fetal blood flow
Two-dimensional cine phase-contrast (PC) MRI is the non-invasive gold standard for vessel flow assessment in children and adults (31). However, the requirements for adequate spatial and temporal resolution limit the application of phase contrast for fetal vessel flow quantification to the larger vessels in the third trimester. The development of metric optimized gating led to the initial descriptions of fetal vessel flow quantification by CMR, and preliminary reference ranges for the distribution of the late gestation normal human fetal circulation (57). Vessel flows were also acquired using this approach in fetuses with CHD and FGR (43, 37, 58). In 2018, Goolaub et al. reported improved image quality using golden angle radial PC CMR with motion correction (35). “Four-dimensional (4D) flow” refers to the acquisition of volumetric datasets that incorporate multidirectional velocity encoding. This data can be reconstructed in any plane to measure vessel flow in an analogous approach to conventional 2D cine phase contrast imaging. 4D flow datasets can also be used to generate more complex reconstructions such as particle tracking that provide unique information about flow patterns within the heart and vessels. This approach has been applied in adult patients to assess aortic aneurysms and valvular conditions, as well as the complex hemodynamics of single ventricle physiology (157). Schrauben et al. (158) applied 4D flow in fetal sheep to visualize the streaming of the umbilical venous return across the foramen ovale via the ductus venosus, providing novel information regarding the spiraling course of flow through the ductus venosus and confirming the mechanism that results in a gradient in oxygen saturations between the right and left heart. Darby et al. (51) then used 4D flow in combination with T2 oximetry to show that pharmacologically induced dilation of the ductus venosus results in an increased shunting of umbilical venous return through the ductus venosus without resulting in increased cerebral oxygen delivery. This method was also applied to visualize hepatic blood flow (152) and changes in flow through the ductus arteriosus at birth (49). Owing to motion corruption during human fetal MRI, direct 3D imaging is often challenging. To address this issue, slice-to-volume reconstruction (SVR) combines multiple stacks of slices with co-registration allowing for volumetric fetal imaging. Multi-slice multiplanar accelerated PC MRI via golden-angle radial acquisition allows retrospective real-time image reconstruction with a high temporal and spatial resolution enabling motion correction and fetal heart rate estimation (32, 159, 160). Flow-sensitive cine imaging can be reconstructed and combined into a 4D flow volume with SVR, allowing comparable visualization of human fetal streaming patterns (33), as shown in Figure 6.
Figure 6. Tracing blood from inferior vena cava (IVC) and ductus venosus (DV) in a human fetal heart (A–C). Coronal view showing blood from the IVC (blue) and DV (red) at different cardiac phases over two heartbeats. Streams from IVC and DV with limited mixing enter the right atrium (A), with blood from the DV (oxygenated) being mainly directed into the left ventricle (B) to supply the coronaries and upper fetal body (C). (D) Corresponding flow map. Adapted from (33).
Ventricular volumetry
A key component of the assessment of ventricular function by CMR is ventricular volumetry, whereby the endocardial and epicardial borders of the ventricles are contoured throughout a stack of cine MR images to measure right and left ventricular myocardial mass, end-systolic, end-diastolic and therefore stroke volumes as well as ejection fractions and CVO (31, 161). In late gestation anesthetized fetal sheep, ventricular volumetry can be obtained using a standard balanced steady state free precession (bSSFP) sequence with contiguous short axis cine images acquired using the blood pressure waveform obtained from an arterial catheter for cardiac triggering. This approach has confirmed the larger end-diastolic volume and stroke volume of the right ventricle than the left in the fetal circulation. Of note, right and left ventricular ejection fractions are not significantly different in the prenatal heart, presumably due to differences in loading conditions. The application of ventricular volumetry in human fetuses has been described in case reports as shown in Figure 7. However, this approach has not yet been reported in any systematic way due to the challenges to accurate ventricular volumetry posed by fetal motion (40).
Figure 7. The application of ventricular volumetry in late gestation fetal sheep (A,B) and human fetus (C). (A,B) In fetal sheep, manual endocardial contours were applied on the stack of short-axis cine acquisitions in systole and diastole (A) to generate a 3D reconstruction of the right and left ventricles (B). (C) Morphological and quantitative models (green, mass 40 mm3) of a human fetal heart with a cardiac rhabdomyoma (red), and the compressed left ventricle (yellow). Adapted from (31) (A,B) and (40) (C).
Myocardial strain
CMR also offers ways of measuring myocardial strain and can be broadly categorized into myocardial tagging and feature tracking. Myocardial tagging works by creating locally induced perturbations of the magnetization of the myocardial tissue prior to image acquisitions and these intrinsic markers, known as tags, move with the underlying tissue allowing quantification of myocardial deformation (162, 163). Tagging is widely accepted as the reference standard in the CMR community and has been validated extensively (164–172). However, it requires a dedicated sequence and time-consuming prost-processing. Moreover, the tags are typically deposited at detection of the QRS complex and introduces approximately a 30 ms delay, which may be particularly limiting in fetal population that has a rapid heart rate, underestimating myocardial strain (163). On the other hand, feature tracking does not necessitate a dedicated sequence and can be readily applied on typically acquired SSFP cine acquisitions (173, 174). Since its introduction in 2009, feature tracking has gained wide acceptance and has been extensively validated against myocardial tagging (175–179). However, given the current lack of standardization of methods and softwares for data analysis, its clinical translation is sparse and is mostly limited to research-oriented environment. CMR myocardial strain may prove useful in assessing regional myocardial dysfunction, and feature tracking has been explored as an approach to detecting wall motion abnormalities in a fetal sheep model of myocardial infarction. In our model, twin sheep fetuses were included in the study, whereby a branch of the left anterior descending coronary artery was ligated to induce a myocardial infarction with the other fetus serving as a sham control (44), as seen in Figure 8.
Figure 8. Gadolinium imaging (left) and SSFP short-axis cine feature tracking analysis (right) in a fetal sheep model of myocardial infarction on the day of surgery and 6 days post-surgery in both injured and sham twins suggesting good correlation between regional myocardial dysfunction in the apical left ventricular lateral wall and evidence of myocardial infarction in the respective segments in early and late gadolinium enhancement imaging. Anterolateral ischemia was noted at day of surgery from apex to near-mid ventricle (top row; early gadolinium enhancement; white arrow) and there was regional myocardial dysfunction in apical segments as measured by decreased circumferential strain by feature tracking (top row; right). 6 days after the myocardial infarction surgery, injury was noted in similar regions (bottom row; late gadolinium enhancement; white arrow) and there was regional myocardial dysfunction in the same regions, overall showing good correlation between injury and regional dysfunction measured by regional circumferential strain by feature tracking. In both scans, the internal sham control (fetus B) remained asymptomatic and did not demonstrate any regional wall motion abnormalities.
Limitation
The accurate assessment of fetal heart function can be challenged by technical factors arising from the small size of the fetal heart, frequent fetal body motion and high fetal heart rate. The reliability of post-processing techniques for assessing cardiac function depends on image quality and structural detail, which has limited the routine application of techniques like speckle tracking for the clinical assessment of fetal cardiac function. Similar factors have limited the widespread adoption of fetal CMR. Compared with ultrasound, MRI is more expensive and less portable, and a clinical role for fetal CMR has not yet been established. MRI is typically more time consuming to acquire and process than ultrasound, which is exacerbated in the setting of fetal imaging due to artifacts resulting from fetal motion (18). A major limitation of fetal CMR arises from the intrinsic tradeoff between obtaining an adequate SNR to resolve small structures and high heart rates, while attempting to overcome artifacts arising from fetal motion by limiting scan time (34). In addition, organizational factors such as the availability of equipment and personnel to conduct fetal CMR must also be considered.
Conclusions
Functional assessment of the fetal heart can be undertaken using a range of techniques. Conventional grey-scale ultrasound imaging is typically used to gain a subjective impression of global cardiac function, while 2D speckle tracking for strain imaging has provided a promising new approach to generating a quantitative assessment of ventricular function in a routine clinical setting. Fetal CMR represents an exciting development with the potential to augment the assessment of fetal cardiac function through techniques like ventricular volumetry and feature tracking. However, challenges to the widespread implementation of these approaches arise from the limitations imposed by fetal imaging, including the small size of the fetal heart, high heart rates and difficulties in obtaining standard views with adequate image quality. Further efforts to improve fetal cardiac imaging will be needed to exploit the full potential of fetal cardiac functional assessment, which is an important objective in the setting of advances in fetal cardiac diagnosis and therapy.
Table 1. Reference ranges for LV and RV longitudinal strain and strain rate by echocardiography in healthy fetuses reported in the literature.
Author contributions
LS and MS: conceived the review. HK and LS: performed the literature review and drafted the manuscript. SC, NB, DG, and JD: worked on the specific sections. JM, CH, LS, and MS: reviewed and edited the manuscript. All authors contributed to the article and approved the submitted version.
Acknowledgment
The authors thank the Fetal Cardiac Program at The Hospital for Sick Children, University of Toronto and Dr. Christopher K. Macgowan and his team for the collaborations with fetal CMR.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Donofrio MT, Moon-Grady AJ, Hornberger LK, Copel JA, Sklansky MS, Abuhamad A, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American heart association. Circulation. (2014) 129(21):2183–242. doi: 10.1161/01.cir.0000437597.44550.5d
2. Sepulveda W, Wong AE, Sepulveda F, Martinez-Ten P, Ximenes R. Fetal magnetic resonance imaging and three-dimensional ultrasound in clinical practice: general aspects. Best Pract Res Clin Obstet Gynaecol. (2012) 26(5):575–91. doi: 10.1016/j.bpobgyn.2012.05.010
3. Crispi F, Valenzuela-Alcaraz B, Cruz-Lemini M, Gratacós E. Ultrasound assessment of fetal cardiac function. Australas J Ultrasound Med. (2013) 16(4):158–67. doi: 10.1002/j.2205-0140.2013.tb00242.x
4. Di Salvo G, Russo MG, Paladini D, Felicetti M, Castaldi B, Tartaglione A, et al. Two-dimensional strain to assess regional left and right ventricular longitudinal function in 100 normal foetuses. Eur J Echocardiogr. (2008) 9(6):754–6. doi: 10.1093/ejechocard/jen134
5. Abuhamad A, Chaoui R. A practical guide to fetal echocardiography: Normal and abnormal hearts. 4 edn. Philadelphia: Lippincott Williams & Wilkins (2022).
6. Van Mieghem T, DeKoninck P, Steenhaut P, Deprest J. Methods for prenatal assessment of fetal cardiac function. Prenat Diagn. (2009) 29(13):1193–203. doi: 10.1002/pd.2379
7. Crispi F, Sepulveda-Swatson E, Cruz-Lemini M, Rojas-Benavente J, Garcia-Posada R, Dominguez JM, et al. Feasibility and reproducibility of a standard protocol for 2D speckle tracking and tissue Doppler-based strain and strain rate analysis of the fetal heart. Fetal Diagn Ther. (2012) 32(1–2):96–108. doi: 10.1159/000337329
8. Wang XF. The use of fetal echocardiography for pregnancy diagnosis. Chin J Obstet Gynecol. (1964) 7:411–4.
9. Maulik D, Nanda NC, Maulik D, Vilchez G. A brief history of fetal echocardiography and its impact on the management of congenital heart disease. Echocardiography. (2017) 34(12):1760–7. doi: 10.1111/echo.13713
10. Deng J, Papageorghiou AT, Xie M. From dotted lines to fetal cardiology: the pioneering contribution of Xin-fang wang (1934–2021). Ultrasound Obstet Gyne. (2022) 59(5):574–5. doi: 10.1002/uog.24881
11. Younoszai AK, Saudek DE, Emery SP, Thomas JD. Evaluation of myocardial mechanics in the fetus by velocity vector imaging. J Am Soc Echocardiogr. (2008) 21(5):470–4. doi: 10.1016/j.echo.2007.08.003
12. Germanakis I, Gardiner H. Assessment of fetal myocardial deformation using speckle tracking techniques. Fetal Diagn Ther. (2012) 32(1–2):39–46. doi: 10.1159/000330378
13. Willruth AM, Geipel AK, Fimmers R, Gembruch UG. Assessment of right ventricular global and regional longitudinal peak systolic strain, strain rate and velocity in healthy fetuses and impact of gestational age using a novel speckle/feature-tracking based algorithm. Ultrasound Obstet Gynecol. (2011) 37(2):143–9. doi: 10.1002/uog.7719
14. Rosner A, Bijnens B, Hansen M, How OJ, Aarsaether E, Muller S, et al. Left ventricular size determines tissue Doppler-derived longitudinal strain and strain rate. Eur J Echocardiogr. (2008) 10(2):271–7. doi: 10.1093/ejechocard/jen230
15. Yamamura J, Schnackenburg B, Kooijmann H, Frisch M, Hecher K, Adam G, et al. High resolution MR imaging of the fetal heart with cardiac triggering: a feasibility study in the sheep fetus. Eur Radiol. (2009) 19(10):2383–90. doi: 10.1007/s00330-009-1420-8
16. Sklansky MS, Nelson TR, Pretorius DH. Three-dimensional fetal echocardiography: gated versus nongated techniques. J Ultrasound Med. (1998) 17(7):451–7. doi: 10.7863/jum.1998.17.7.451
17. Voigt J-U, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann R, et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/industry task force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging. (2015) 16:1–11. doi: 10.1093/ehjci/jeu184
18. Godfrey ME, Messing B, Cohen SM, Valsky DV, Yagel S. Functional assessment of the fetal heart: a review. Ultrasound Obstet Gynecol. (2012) 39(2):131–44. doi: 10.1002/uog.9064
19. Sun L, Lee FT, van Amerom JFP, Freud L, Jaeggi E, Macgowan CK, et al. Update on fetal cardiovascular magnetic resonance and utility in congenital heart disease. J Congenit Heart Dis. (2021) 5(1):4. doi: 10.1186/s40949-021-00059-x
20. Haris K, Hedström E, Bidhult S, Testud F, Maglaveras N, Heiberg E, et al. Self-gated fetal cardiac MRI with tiny golden angle iGRASP: a feasibility study. J Magn Reson Imaging. (2017) 46(1):207–17. doi: 10.1002/jmri.25599
21. Larson AC, White RD, Laub G, McVeigh ER, Li D, Simonetti OP. Self-gated cardiac cine MRI. Magn Reson Med. (2004) 51(1):93–102. doi: 10.1002/mrm.10664
22. Hoerr V, Nagelmann N, Nauerth A, Kuhlmann MT, Stypmann J, Faber C. Cardiac-respiratory self-gated cine ultra-short echo time (UTE) cardiovascular magnetic resonance for assessment of functional cardiac parameters at high magnetic fields. J Cardiovasc Magn Reson. (2013) 15(1):59. doi: 10.1186/1532-429X-15-59
23. Chaptinel J, Yerly J, Mivelaz Y, Prsa M, Alamo L, Vial Y, et al. Fetal cardiac cine magnetic resonance imaging in utero. Sci Rep. (2017) 7(1):15540. doi: 10.1038/s41598-017-15701-1
24. Yamamura J, Frisch M, Ecker H, Graessner J, Hecher K, Adam G, et al. Self-gating MR imaging of the fetal heart: comparison with real cardiac triggering. Eur Radiol. (2011) 21(1):142–9. doi: 10.1007/s00330-010-1911-7
25. Lloyd DFA, Pushparajah K, Simpson JM, van Amerom JFP, van Poppel MPM, Schulz A, et al. Three-dimensional visualisation of the fetal heart using prenatal MRI with motion-corrected slice-volume registration: a prospective, single-centre cohort study. Lancet. (2019) 393(10181):1619–27. doi: 10.1016/S0140-6736(18)32490-5
26. Roy CW, Seed M, Macgowan CK. Accelerated MRI of the fetal heart using compressed sensing and metric optimized gating. Magn Reson Med. (2017) 77(6):2125–35. doi: 10.1002/mrm.26290
27. Jansz MS, Seed M, van Amerom JFP, Wong D, Grosse-Wortmann L, Yoo SJ, et al. Metric optimized gating for fetal cardiac MRI. Magn Reson Med. (2010) 64(5):1304–14. doi: 10.1002/mrm.22542
28. Roy CW, Seed M, van Amerom JFP, Al Nafisi B, Grosse-Wortmann L, Yoo SJ, et al. Dynamic imaging of the fetal heart using metric optimized gating. Magn Reson Med. (2013) 70(6):1598–607. doi: 10.1002/mrm.24614
29. van Amerom JF, Goolaub DS, Schrauben EM, Sun L, Macgowan CK, Seed M. Fetal cardiovascular blood flow MRI: techniques and applications. BJR. (2022) 28:20211096. doi: 10.1259/bjr.20211096
30. Kording F, Yamamura J, de Sousa MT, Ruprecht C, Hedström E, Aletras AH, et al. Dynamic fetal cardiovascular magnetic resonance imaging using Doppler ultrasound gating. J Cardiovasc Magn Reson. (2018) 20(1):17. doi: 10.1186/s12968-018-0440-4
31. Cho SKS, Darby JRT, Saini BS, Lock MC, Holman SL, Lim JM, et al. Feasibility of ventricular volumetry by cardiovascular MRI to assess cardiac function in the fetal sheep. J Physiol. (2020) 598(13):2557–73. doi: 10.1113/JP279054
32. Goolaub DS, Xu J, Schrauben E, Sun L, Roy CW, Marini D, et al. Fetal flow quantification in great vessels using motion-corrected radial phase contrast MRI: comparison with cartesian. J Magn Reson Imaging. (2021) 53(2):540–51. doi: 10.1002/jmri.27334
33. Goolaub DS, Xu J, Schrauben EM, Marini D, Kingdom JC, Sled JG, et al. Volumetric fetal flow imaging with magnetic resonance imaging. IEEE Trans Med Imaging. (2022) 41(10):2941–52. doi: 10.1109/TMI.2022.3176814
34. Roy CW, van Amerom JFP, Marini D, Seed M, Macgowan CK. Fetal cardiac MRI: a review of technical advancements. Top Magn Reson Imaging. (2019) 28(5):235–44. doi: 10.1097/RMR.0000000000000218
35. Goolaub DS, Roy CW, Schrauben E, Sussman D, Marini D, Seed M, et al. Multidimensional fetal flow imaging with cardiovascular magnetic resonance: a feasibility study. J Cardiovasc Magn Reson. (2018) 20(1):77. doi: 10.1186/s12968-018-0498-z
36. Roy CW, Marini D, Lloyd DFA, Mawad W, Yoo SJ, Schrauben EM, et al. Preliminary experience using motion compensated CINE magnetic resonance imaging to visualise fetal congenital heart disease: comparison to echocardiography. Circ Cardiovasc Imaging. (2018) 11(12):e007745. doi: 10.1161/CIRCIMAGING.118.007745
37. Sun L, van Amerom JFP, Marini D, Portnoy S, Lee FT, Saini BS, et al. MRI Characterization of hemodynamic patterns of human fetuses with cyanotic congenital heart disease. Ultrasound Obstet Gynecol. (2021) 58(6):824–36. doi: 10.1002/uog.23707
38. Tavares de Sousa M, Hecher K, Yamamura J, Kording F, Ruprecht C, Fehrs K, et al. Dynamic fetal cardiac magnetic resonance imaging in four-chamber view using Doppler ultrasound gating in normal fetal heart and in congenital heart disease: comparison with fetal echocardiography. Ultrasound Obstet Gynecol. (2019) 53(5):669–75. doi: 10.1002/uog.20167
39. Schrauben EM, Lim JM, Goolaub DS, Marini D, Seed M, Macgowan CK. Motion robust respiratory-resolved 3D radial flow MRI and its application in neonatal congenital heart disease. Magn Reson Med. (2020) 83(2):535–48. doi: 10.1002/mrm.27945
40. Marini D, Xu J, Sun L, Jaeggi E, Seed M. Current and future role of fetal cardiovascular MRI in the setting of fetal cardiac interventions. Prenat Diagn. (2020) 40(1):71–83. doi: 10.1002/pd.5626
41. Aguet J, Seed M, Marini D. Fetal cardiovascular magnetic resonance imaging. Pediatr Radiol. (2020) 50(13):1881–94. doi: 10.1007/s00247-020-04902-y
42. Seed M, van Amerom FPJ, Yoo SJ, Al Nafisi B, Grosse-Wortmann L, Jaeggi E, et al. Feasibility of quantification of the distribution of blood flow in the normal human fetal circulation using CMR: a cross-sectional study. J Cardiovasc Magn Reson. (2012) 14(1):79. doi: 10.1186/1532-429X-14-79
43. Sun L, Macgowan CK, Sled JG, Yoo SJ, Manlhiot C, Porayette P, et al. Reduced fetal cerebral oxygen consumption is associated with smaller brain size in fetuses with congenital heart disease. Circulation. (2015) 131(15):1313–23. doi: 10.1161/CIRCULATIONAHA.114.013051
44. Duan AQ, Lock MC, Perumal SR, Darby JR, Soo JY, Selvanayagam JB, et al. Feasibility of detecting myocardial infarction in the sheep fetus using late gadolinium enhancement CMR imaging. J Cardiovasc Magn Reson. (2017) 19(1):69. doi: 10.1186/s12968-017-0383-1
45. Cho S, Darby J, Lock M, Macgowan C, Selvanayagam J, Morrison J, et al. Comprehensive characterisation of left ventricular myocardial function by cardiac magnetic resonance feature tracking in an adolescent sheep model of myocardial infarction. Heart Lung Circulation. (2021) 30:S183. doi: 10.1016/j.hlc.2021.06.199
46. Flouri D, Darby JRT, Holman SL, Perumal SR, David AL, Morrison JL, et al. Magnetic resonance imaging of placentome development in the pregnant ewe. Placenta. (2021) 105:61–9. doi: 10.1016/j.placenta.2021.01.017
47. Saini BS, Darby JRT, Marini D, Portnoy S, Lock MC, Yin Soo J, et al. An MRI approach to assess placental function in healthy humans and sheep. J Physiol. (2021) 599(10):2573–602. doi: 10.1113/JP281002
48. Morrison JL, Williams GK, Cho SKS, Saini BS, Meakin AS, Holman SL, et al. MRI Characterization of blood flow and oxygen delivery in the fetal sheep whilst exposed to sildenafil citrate. Neonatology. (2022) 119(6):735–44. doi: 10.1159/000526972
49. Schrauben EM, Darby JRT, Berry MJ, Saini BS, Quinn M, Holman SL, et al. Open or closed: changes in ductus arteriosus flow patterns at birth using 4D flow MRI in newborn piglets. Physiol Rep. (2021) 9(17):e14999. doi: 10.14814/phy2.14999
50. Duan AQ, Darby JRT, Soo JY, Lock MC, Zhu MY, Flynn LV, et al. Feasibility of phase-contrast cine magnetic resonance imaging for measuring blood flow in the sheep fetus. Am J Physiol Regul Integr Comp Physiol. (2019) 317(6):R780–92. doi: 10.1152/ajpregu.00273.2017
51. Darby JRT, Schrauben EM, Saini BS, Holman SL, Perumal SR, Seed M, et al. Umbilical vein infusion of prostaglandin I2 increases ductus venosus shunting of oxygen-rich blood but does not increase cerebral oxygen delivery in the fetal sheep. J Physiol. (2020) 598(21):4957–67. doi: 10.1113/JP280019
52. Hassan HGEMA, Habeeb NMM, Ibrahim AS, Megahed SR, Yassin A. Feasibility study in assessment of congenital cardiovascular malformation by recent technique of fetal cardiac MR imaging. Egypt J Radiol Nucl Med. (2022) 53(1):98. doi: 10.1186/s43055-022-00771-7
53. Li X, Li X, Saul D, Zhao Z. Fetal MRI diagnosis of 2 types of left pulmonary artery sling. Radiol Case Rep. (2017) 12(4):653–7. doi: 10.1016/j.radcr.2017.07.013
54. Li X, Li X, Hu K, Yin C. The value of cardiovascular magnetic resonance in the diagnosis of fetal aortic arch anomalies. J Matern Fetal Neonatal Med. (2017) 30(11):1366–71. doi: 10.1080/14767058.2016.1214126
55. Roberts TA, van Amerom JFP, Uus A, Lloyd DFA, van Poppel MPM, Price AN, et al. Fetal whole heart blood flow imaging using 4D cine MRI. Nat Commun. (2020) 11(1):4992. doi: 10.1038/s41467-020-18790-1
56. van Amerom JF, Lloyd DF, Deprez M, Price AN, Malik SJ, Pushparajah K, et al. Fetal whole-heart 4D imaging using motion-corrected multi-planar real-time MRI. Magn Reson Med. (2019) 82:1055–72. doi: 10.1002/mrm.27798
57. Prsa M, Sun L, van Amerom J, Yoo SJ, Grosse-Wortmann L, Jaeggi E, et al. Reference ranges of blood flow in the Major vessels of the normal human fetal circulation at term by phase-contrast magnetic resonance imaging. Circ Cardiovasc Imaging. (2014) 7(4):663–70. doi: 10.1161/CIRCIMAGING.113.001859
58. Zhu MY, Milligan N, Keating S, Windrim R, Keunen J, Thakur V, et al. The hemodynamics of late-onset intrauterine growth restriction by MRI. Am J Obstet Gynecol. (2016) 214(3):367.e1–367.e17. doi: 10.1016/j.ajog.2015.10.004
59. Portnoy S, Seed M, Sled JG, Macgowan CK. Non-invasive evaluation of blood oxygen saturation and hematocrit from T 1 and T 2 relaxation times: in-vitro validation in fetal blood: non-invasive evaluation of blood oxygen saturation and hematocrit from T 1 and T 2 : in-vitro validation in fetal blood. Magn Reson Med. (2017) 78(6):2352–9. doi: 10.1002/mrm.26599
60. Xu J, Duan AQ, Marini D, Lim JM, Keunen J, Portnoy S, et al. The utility of MRI for measuring hematocrit in fetal anemia. Am J Obstet Gynecol. (2020) 222(1):81.e1–81.e13. doi: 10.1016/j.ajog.2019.07.016
61. Seed M, Bradley T, Bourgeois J, Jaeggi E, Yoo SJ. Antenatal MR imaging of pulmonary lymphangiectasia secondary to hypoplastic left heart syndrome. Pediatr Radiol. (2009) 39(7):747–9. doi: 10.1007/s00247-009-1223-8
62. Al Nafisi B, van Amerom JF, Forsey J, Jaeggi E, Grosse-Wortmann L, Yoo SJ, et al. Fetal circulation in left-sided congenital heart disease measured by cardiovascular magnetic resonance: a case–control study. J Cardiovasc Magn Reson. (2013) 15(1):65. doi: 10.1186/1532-429X-15-65
63. Porayette P, Madathil S, Sun L, Jaeggi E, Grosse-Wortmann L, Yoo SJ, et al. MRI Reveals hemodynamic changes with acute maternal hyperoxygenation in human fetuses with and without congenital heart disease: fetal MRI reveals hemodynamic effects of oxygen in humans. Prenat Diagn. (2016) 36(3):274–81. doi: 10.1002/pd.4762
64. Flouri D, Darby JRT, Holman SL, Cho SKS, Dimasi CG, Perumal SR, et al. Placental MRI predicts fetal oxygenation and growth rates in sheep and human pregnancy. Adv Sci. (2022) 9(30):2203738. doi: 10.1002/advs.202203738
65. Wood D, Respondek-Liberska M, Puerto B, Weiner S. Perinatal echocardiography: protocols for evaluating the fetal and neonatal heart. J Perinat Med. (2009) 37(1):5–11. doi: 10.1515/JPM.2009.022
66. AIUM Practice guideline for the performance of obstetric ultrasound examinations. J Ultrasound Med. (2013) 32(6):1083–101. doi: 10.7863/jum.2013.32.6.1083
67. ISUOG Practice guidelines: use of Doppler ultrasonography in obstetrics. Ultrasound Obstet Gynecol. (2013) 41(2):233–9. doi: 10.1002/uog.12371
68. Carvalho J, Allan L, Chaoui R, Copel J, DeVore G, Hecher K, et al. ISUOG Practice guidelines (updated): sonographic screening examination of the fetal heart: ISUOG guidelines. Ultrasound Obstet Gynecol. (2013) 41(3):348–59. doi: 10.1002/uog.12403
69. Wax J, Minkoff H, Johnson A, Coleman B, Levine D, Helfgott A, et al. Consensus report on the detailed fetal anatomic ultrasound examination: indications, components, and qualifications. J Ultrasound Med. (2014) 33(2):189–95. doi: 10.7863/ultra.33.2.189
70. Reddy UM, Abuhamad AZ, Levine D, Saade GR, for the Fetal Imaging Workshop Invited Participants. Fetal imaging: executive summary of a joint eunice kennedy shriver national institute of child health and human development, society for maternal-fetal medicine, ame. J Ultrasound Med. (2014) 33(5):745–57. doi: 10.7863/ultra.33.5.745
71. DiLorenzo MP, Bhatt SM, Mercer-Rosa L. How best to assess right ventricular function by echocardiography. Cardiol Young. (2015) 25(8):1473–81. doi: 10.1017/S1047951115002255
72. AIUM-ACR-ACOG-SMFM-SRU practice parameter for the performance of standard diagnostic obstetric ultrasound examinations. J Ultrasound Med. (2018) 37(11):E13–24. doi: 10.1002/jum.14831
73. AIUM Practice parameter for the performance of fetal echocardiography. J Ultrasound Med. (2020) 39(1):E5–16. doi: 10.1002/jum.15188
74. Allan LD, Joseph MC, Boyd EG, Campbell S, Tynan M. M-mode echocardiography in the developing human fetus. Br Heart J. (1982) 47(6):573–83. doi: 10.1136/hrt.47.6.573
75. DeVore GR, Horenstein J, Siassi B, Platt LD. Fetal echocardiography. Am J Obstet Gynecol. (1987) 156(5):1054–64. doi: 10.1016/0002-9378(87)90110-4
76. Schneider M, Aschauer S, Mascherbauer J, Ran H, Binder C, Lang I, et al. Echocardiographic assessment of right ventricular function: current clinical practice. Int J Cardiovasc Imaging. (2019) 35(1):49–56. doi: 10.1007/s10554-018-1428-8
77. Weidemann F, Kowalski M, D’hooge J, Bijnens B, Sutherland GR. Doppler Myocardial imaging. A new tool to assess regional inhomogeneity in cardiac function. Basic Res Cardiol. (2001) 96(6):595–605. doi: 10.1007/s003950170011
78. Matsui H, Germanakis I, Kulinskaya E, Gardiner HM. Temporal and spatial performance of vector velocity imaging in the human fetal heart. Ultrasound Obstet Gynecol. (2011) 37(2):150–7. doi: 10.1002/uog.8815
79. Luo L, Liu H, Zhou S, Zhao F, Zhu Q, Guo N, et al. Quantitative evaluation of fetal ventricular function by speckle tracking echocardiography. Echocardiography. (2021) 38(11):1924–31. doi: 10.1111/echo.15240
80. Peng QH, Zhou QC, Zeng S, Tian LQ, Zhang M, Tan Y, et al. Evaluation of regional left ventricular longitudinal function in 151 normal fetuses using velocity vector imaging. Prenat Diagn. (2009) 29(12):1149–55. doi: 10.1002/pd.2386
81. Zhang LJ, Chen KQ, Shi YY, Zheng XZ. Fetal regional myocardial strain rate in the membranous ventricular septum: changes with gestational age and the left ventricular mass and predictive value for a complete membranous ventricular septum (without defect). Int J Cardiovasc Imaging. (2018) 34(9):1403–8. doi: 10.1007/s10554-018-1354-9
82. Falkensammer CB, Paul J, Huhta JC. Fetal congestive heart failure: correlation of tei-index and cardiovascular-score. J Perinat Med. (2001) 29(5):390–8. doi: 10.1515/JPM.2001.055
83. Eidem BW, Edwards JM, Cetta F. Quantitative assessment of fetal ventricular function: establishing normal values of the myocardial performance Index in the Fetus. Echocardiography. (2001) 18(1):9–13. doi: 10.1046/j.1540-8175.2001.t01-1-00009.x
84. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function–a study in normals and dilated cardiomyopathy. J Cardiol. (1995) 26(6):357–66. doi: 10.1016/S0894-7317(05)80111-7
85. Hofstaetter C, Hofstaetter C, Hansmann M, Eik-Nes SH, Huhta JC, Luther SL. A cardiovascular profile score in the surveillance of fetal hydrops. J Matern Fetal Neonatal Med. (2006) 19(7):407–13. doi: 10.1080/14767050600682446
86. Mäkikallio K, Räsänen J, Mäkikallio T, Vuolteenaho O, Huhta JC. Human fetal cardiovascular profile score and neonatal outcome in intrauterine growth restriction. Ultrasound Obstet Gynecol. (2008) 31(1):48–54. doi: 10.1002/uog.5210
87. Aoki M, Harada K, Ogawa M, Tanaka T. Quantitative assessment of right ventricular function using Doppler tissue imaging in fetuses with and without heart failure. J Am Soc Echocardiogr. (2004) 17(1):28–35. doi: 10.1016/j.echo.2003.09.012
88. Tsutsumi T, Ishii M, Eto G, Hota M, Kato H. Serial evaluation for myocardial performance in fetuses and neonates using a new Doppler index. Pediatr Int. (1999) 41(6):722–7. doi: 10.1046/j.1442-200x.1999.01155.x
89. Huhta JC. Guidelines for the evaluation of heart failure in the fetus with or without hydrops. Pediatr Cardiol. (2004) 25(3):274–86. doi: 10.1007/s00246-003-0591-3
90. DeVore GR, Klas B, Satou G, Sklansky M. Quantitative evaluation of fetal right and left ventricular fractional area change using speckle-tracking technology. Ultrasound Obstet Gynecol. (2019) 53(2):219–28. doi: 10.1002/uog.19048
91. Hu H, Huang H, Li M, Gao X, Yin L, Qi R, et al. A wearable cardiac ultrasound imager. Nature. (2023) 613(7945):667–75. doi: 10.1038/s41586-022-05498-z
92. Bulwer BE, Solomon SD, Janardhanan R. Echocardiographic assessment of ventricular systolic function. In: Solomon SD, Bulwer B, editors. Essential echocardiography. Totowa, NJ: Humana Press (2007). p. 89–117. (Contemporary Cardiology). Available at: http://link.springer.com/10.1007/978-1-59259-977-6_5 (cited 2023 Jan 10).
93. Ozawa K, Davey MG, Tian Z, Hornick MA, Mejaddam AY, McGovern PE, et al. Fetal echocardiographic assessment of cardiovascular impact of prolonged support on EXTrauterine environment for neonatal development (EXTEND) system. Ultrasound Obstet Gynecol. (2020) 55(4):516–22. doi: 10.1002/uog.20295
94. Matias A. Haemodynamic evaluation of the first trimester fetus with special emphasis on venous return. Hum Reprod Update. (2000) 6(2):177–89. doi: 10.1093/humupd/6.2.177
95. Hecher K, Campbell S, Snijders R, Nicolaides K. Reference ranges for fetal venous and atrioventricular blood flow parameters. Ultrasound Obstet Gynecol. (1994) 4(5):381–90. doi: 10.1046/j.1469-0705.1994.04050381.x
96. Barker PCA, Houle H, Li JS, Miller S, Herlong JR, Camitta MGW. Global longitudinal cardiac strain and strain rate for assessment of fetal cardiac function: novel experience with velocity vector imaging. Echocardiography. (2009) 26(1):28–36. doi: 10.1111/j.1540-8175.2008.00761.x
97. Kiserud T, Kessler J, Ebbing C, Rasmussen S. Ductus venosus shunting in growth-restricted fetuses and the effect of umbilical circulatory compromise. Ultrasound Obstet Gynecol. (2006) 28(2):143–9. doi: 10.1002/uog.2784
98. Kiserud T, Eik-Nes SH, Blaas HG, Hellevik LR, Simensen B. Ductus venosus blood velocity and the umbilical circulation in the seriously growth-retarded fetus. Ultrasound Obstet Gynecol. (1994) 4(2):109–14. doi: 10.1046/j.1469-0705.1994.04020109.x
99. Braga M, Moleiro ML, Guedes-Martins L. Clinical significance of ductus venosus waveform as generated by pressure- volume changes in the fetal heart. CCR. (2019) 15(3):167–76. doi: 10.2174/1573403X15666190115142303
100. Dahlbäck C, Pihlsgård M, Gudmundsson S. Abnormal ductus venosus pulsatility index in the absence of concurrent umbilical vein pulsations does not indicate worsening fetal condition. Ultrasound Obstet Gynecol. (2013) 42(3):322–8. doi: 10.1002/uog.12411
101. Rudolph AM. Congenital diseases of the heart: clinical-physiological considerations. 3rd ed. Chichester, UK ; Hoboken, NJ: Wiley-Blackwell (2009). 538.
102. Hecher K, Campbell S, Doyle P, Harrington K, Nicolaides K. Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation: arterial, intracardiac, and venous blood flow velocity studies. Circulation. (1995) 91(1):129–38. doi: 10.1161/01.CIR.91.1.129
103. Oros D, Ruiz-Martinez S, Staines-Urias E, Conde-Agudelo A, Villar J, Fabre E, et al. Reference ranges for Doppler indices of umbilical and fetal middle cerebral arteries and cerebroplacental ratio: systematic review. Ultrasound Obstet Gynecol. (2019) 53(4):454–64. doi: 10.1002/uog.20102
104. Bhide A, Acharya G, Baschat A, Bilardo CM, Brezinka C, Cafici D, et al. Practice guidelines (updated): use of Doppler velocimetry in obstetrics. Ultrasound Obstet Gyne. (2021) 58(2):331–9. doi: 10.1002/uog.23698
105. Tulzer G, Khowsathit P, Gudmundsson S, Wood DC, Tian ZY, Schmitt K, et al. Diastolic function of the fetal heart during second and third trimester: a prospective longitudinal Doppler-echocardiographic study. Eur J Pediatr. (1994) 153(3):151–4. doi: 10.1007/BF01958973
106. Chiba Y, Kanzaki T, Kobayashi H, Murakami M, Yutani C. Evaluation of fetal structural heart disease using color flow mapping. Ultrasound Med Biol. (1990) 16(3):221–9. doi: 10.1016/0301-5629(90)90001-S
107. Zhou YQ, Cahill LS, Wong MD, Seed M, Macgowan CK, Sled JG. Assessment of flow distribution in the mouse fetal circulation at late gestation by high-frequency Doppler ultrasound. Physiol Genomics. (2014) 46(16):602–14. doi: 10.1152/physiolgenomics.00049.2014
108. DeVore GR, Falkensammer P, Sklansky MS, Platt LD. Spatio-temporal image correlation (STIC): new technology for evaluation of the fetal heart. Ultrasound Obstet Gynecol. (2003) 22(4):380–7. doi: 10.1002/uog.217
109. Sun JX, Cai AL, Xie LM. Evaluation of right ventricular volume and systolic function in normal fetuses using intelligent spatiotemporal image correlation. WJCC. (2019) 7(15):2003–12. doi: 10.12998/wjcc.v7.i15.2003
110. Merz E, Abramowicz JS. 3D/4D Ultrasound in prenatal diagnosis: is it time for routine use? Clin Obstet Gynecol. (2012) 55(1):336–51. doi: 10.1097/GRF.0b013e3182446ef7
111. Alsolai AA, Bligh LN, Greer RM, Gooi A, Kumar S. Myocardial strain assessment using velocity vector imaging in normally grown fetuses at term. Ultrasound Obstet Gynecol. (2018) 52(3):352–8. doi: 10.1002/uog.17549
112. Rai ABS, Lima E, Munir F, Faisal Khan A, Waqas A, Bughio S, et al. Speckle tracking echocardiography of the right atrium: the neglected chamber. Clin Cardiol. (2015) 38(11):692–7. doi: 10.1002/clc.22438
113. Enzensberger C, Achterberg F, Graupner O, Wolter A, Herrmann J, Axt-Fliedner R. Wall-motion tracking in fetal echocardiography—influence of frame rate on longitudinal strain analysis assessed by two-dimensional speckle tracking. Echocardiography. (2017) 34(6):898–905. doi: 10.1111/echo.13542
114. Forsha D, Risum N, Rajagopal S, Dolgner S, Hornik C, Barnhart H, et al. The influence of angle of insonation and target depth on speckle-tracking strain. J Am Soc Echocardiogr. (2015) 28(5):580–6. doi: 10.1016/j.echo.2014.12.015
115. Day TG, Charakida M, Simpson JM. Using speckle-tracking echocardiography to assess fetal myocardial deformation: are we there yet? Ultrasound Obstet Gynecol. (2019) 54(5):575–81. doi: 10.1002/uog.20233
116. Huntley ES, Hernandez-Andrade E, Soto E, DeVore G, Sibai BM. Novel speckle tracking analysis showed excellent reproducibility for size and shape of the fetal heart and good reproducibility for strain and fractional shortening. Fetal Diagn Ther. (2021) 48(7):541–50. doi: 10.1159/000517625
117. Chelliah A, Dham N, Frank LH, Donofrio M, Krishnan A. Myocardial strain can be measured from first trimester fetal echocardiography using velocity vector imaging. Prenat Diagn. (2016) 36(5):483–8. doi: 10.1002/pd.4813
118. Ta-Shma A, Perles Z, Gavri S, Golender J, Tarshansky S, Shlichter C, et al. Analysis of segmental and global function of the fetal heart using novel automatic functional imaging. J Am Soc Echocardiogr. (2008) 21(2):146–50. doi: 10.1016/j.echo.2007.05.007
119. Peters DC, Lamy J, Sinusas AJ, Baldassarre LA. Left atrial evaluation by cardiovascular magnetic resonance: sensitive and unique biomarkers. Eur Heart J Cardiovasc Imaging. (2021) 23(1):14–30. doi: 10.1093/ehjci/jeab221
120. Germanakis I, Matsui H, Gardiner HM. Myocardial strain abnormalities in fetal congenital heart disease assessed by speckle tracking echocardiography. Fetal Diagn Ther. (2012) 32(1–2):123–30. doi: 10.1159/000334413
121. Van Mieghem T, Giusca S, DeKoninck P, Gucciardo L, Doné E, Hindryckx A, et al. Prospective assessment of fetal cardiac function with speckle tracking in healthy fetuses and recipient fetuses of twin-to-twin transfusion syndrome. J Am Soc Echocardiogr. (2010) 23(3):301–8. doi: 10.1016/j.echo.2009.12.024
122. Kapusta L, Mainzer G, Weiner Z, Deutsch L, Khoury A, Haddad S, et al. Second trimester ultrasound: reference values for two-dimensional speckle tracking–derived longitudinal strain, strain rate and time to peak deformation of the fetal heart. J Am Soc Echocardiogr. (2012) 25(12):1333–41. doi: 10.1016/j.echo.2012.09.011
123. Rychik J, Zeng S, Bebbington M, Szwast A, Quartermain M, Natarajan S, et al. Speckle tracking-derived myocardial tissue deformation imaging in twin-twin transfusion syndrome: differences in strain and strain rate between donor and recipient twins. Fetal Diagn Ther. (2012) 32(1–2):131–7. doi: 10.1159/000335403
124. van Oostrum NHM, de Vet CM, van der Woude DAA, Kemps HMC, Oei SG, van Laar JOEH. Fetal strain and strain rate during pregnancy measured with speckle tracking echocardiography: a systematic review. Eur J Obstetr Gynecol Reprod Biol. (2020) 250:178–87. doi: 10.1016/j.ejogrb.2020.04.002
125. Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, et al. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr. (2010) 23(4):351–69. doi: 10.1016/j.echo.2010.02.015
126. DeVore GR, Polanco B, Satou G, Sklansky M. Two-dimensional speckle tracking of the fetal heart: a practical step-by-step approach for the fetal sonologist. J Ultrasound Med. (2016) 35(8):1765–81. doi: 10.7863/ultra.15.08060
127. Kapusta L, Mainzer G, Weiner Z, Deutsch L, Khoury A, Haddad S, et al. Changes in fetal left and right ventricular strain mechanics during normal pregnancy. J Am Soc Echocardiogr. (2013) 26(10):1193–200. doi: 10.1016/j.echo.2013.06.007
128. DeVore GR, Satou G, Sklansky M. Comparing the non-quiver and quiver techniques for identification of the endocardial borders used for speckle-tracking analysis of the ventricles of the fetal heart. J Ultrasound Med. (2021) 40(9):1955–61. doi: 10.1002/jum.15561
129. Farsalinos KE, Daraban AM, Ünlü S, Thomas JD, Badano LP, Voigt JU. Head-to-head comparison of global longitudinal strain measurements among nine different vendors. J Am Soc Echocardiogr. (2015) 28(10):1171–1181.e2. doi: 10.1016/j.echo.2015.06.011
130. Maskatia SA, Pignatelli RH, Ayres NA, Altman CA, Sangi-Haghpeykar H, Lee W. Fetal and neonatal diastolic myocardial strain rate: normal reference ranges and reproducibility in a prospective, longitudinal cohort of pregnancies. J Am Soc Echocardiogr. (2016) 29(7):663–9. doi: 10.1016/j.echo.2016.02.017
131. Charest-Pekeski AJ, Sheta A, Taniguchi L, McVey MJ, Floh A, Sun L, et al. Achieving sustained extrauterine life: challenges of an artificial placenta in fetal pigs as a model of the preterm human fetus. Physiol Rep. (2021) 9(5):e14742. doi: 10.14814/phy2.14742
132. Charest-Pekeski AJ, Cho SKS, Aujla T, Sun L, Floh AA, McVey MJ, et al. Impact of the addition of a centrifugal pump in a preterm miniature pig model of the artificial placenta. Front Physiol. (2022) 13:925772. doi: 10.3389/fphys.2022.925772
133. Uematsu M, Miyatake K, Tanaka N, Matsuda H, Sano A, Yamazaki N, et al. Myocardial velocity gradient as a new indicator of regional left ventricular contraction: detection by a two-dimensional tissue Doppler imaging technique. J Am Coll Cardiol. (1995) 26(1):217–23. doi: 10.1016/0735-1097(95)00158-V
134. Heimdal A, Støylen A, Torp H, Skjærpe T. Real-time strain rate imaging of the left ventricle by ultrasound. J Am Soc Echocardiogr. (1998) 11(11):1013–9. doi: 10.1016/S0894-7317(98)70151-8
135. Harada K, Tsuda A, Orino T, Tanaka T, Takada G. Tissue Doppler imaging in the normal fetus. Int J Cardiol. (1999) 71(3):227–34. doi: 10.1016/S0167-5273(99)00152-7
136. Nesser HJ, Mor-Avi V, Gorissen W, Weinert L, Steringer-Mascherbauer R, Niel J, et al. Quantification of left ventricular volumes using three-dimensional echocardiographic speckle tracking: comparison with MRI. Eur Heart J. (2009) 30(13):1565–73. doi: 10.1093/eurheartj/ehp187
137. Enzensberger C, Degenhardt J, Tenzer A, Doelle A, Axt-Fliedner R. First experience with three-dimensional speckle tracking (3D wall motion tracking) in fetal echocardiography. Ultraschall Med. (2014) 35(06):566–72. doi: 10.1055/s-0034-1384882
138. Ishii T, McElhinney DB, Harrild DM, Marcus EN, Sahn DJ, Truong U, et al. Circumferential and longitudinal ventricular strain in the normal human Fetus. J Am Soc Echocardiogr. (2012) 25(1):105–11. doi: 10.1016/j.echo.2011.09.016
139. Rong PD, Chang ZQ, Zhang M, Hai PQ, Zeng S, Qiong XG. Assessment of regional right ventricular longitudinal functions in fetus using velocity vector imaging technology. Prenat Diagn. (2010) 30(11):1057–63. doi: 10.1002/pd.2611
140. Pérez-Cruz M, Cruz-Lemini M, Fernández MT, Parra JA, Bartrons J, Gómez-Roig MD, et al. Fetal cardiac function in late-onset intrauterine growth restriction vs small-for-gestational age, as defined by estimated fetal weight, cerebroplacental ratio and uterine artery Doppler: cardiac function in late-onset small fetuses. Ultrasound Obstet Gynecol. (2015) 46(4):465–71. doi: 10.1002/uog.14930
141. Di Salvo G, Russo MG, Paladini D, Pacileo G, Felicetti M, Ricci C, et al. Quantification of regional left and right ventricular longitudinal function in 75 normal fetuses using ultrasound-based strain rate and strain imaging. Ultrasound Med Biol. (2005) 31(9):1159–62. doi: 10.1016/j.ultrasmedbio.2005.05.011
142. Willruth AM, Geipel AK, Berg CT, Fimmers R, Gembruch UG. Comparison of global and regional right and left ventricular longitudinal peak systolic strain, strain rate and velocity in healthy fetuses using a novel feature tracking technique. J Perinat Med. (2011) 39(5):549–56. doi: 10.1515/jpm.2011.060
143. Kim SH, Miyakoshi K, Kadohira I, Tanaka M, Minegishi K, Matsumoto T, et al. Comparison of the right and left ventricular performance during the fetal development using velocity vector imaging. Early Hum Dev. (2013) 89(9):675–81. doi: 10.1016/j.earlhumdev.2013.04.015
144. Maskatia SA, Pignatelli RH, Ayres NA, Altman CA, Sangi-Haghpeykar H, Lee W. Longitudinal changes and interobserver variability of systolic myocardial deformation values in a prospective cohort of healthy fetuses across gestation and after delivery. J Am Soc Echocardiogr. (2016 29(4):341–9. doi: 10.1016/j.echo.2015.12.003
145. Dahlbäck C, Gudmundsson S. Increased pulsatility in the fetal ductus venosus is not related to altered cardiac strain in high-risk pregnancies. J Matern Fetal Neonatal Med. (2016) 29(8):1328–33. doi: 10.3109/14767058.2015.1047337
146. Enzensberger C, Achterberg F, Degenhardt J, Wolter A, Graupner O, Herrmann J, et al. Feasibility and reproducibility of two-dimensional wall motion tracking (WMT) in fetal echocardiography. Ultrasound Int Open. (2017) 03(01):E26–33. doi: 10.1055/s-0042-124501
147. Li L, Craft M, Hsu HH, Zhang M, Klas B, Danford DA, et al. Left ventricular rotational and twist mechanics in the human fetal heart. J Am Soc Echocardiogr. (2017) 30(8):773–780.e1. doi: 10.1016/j.echo.2017.04.006
148. DeVore GR, Klas B, Satou G, Sklansky M. Longitudinal annular systolic displacement compared to global strain in normal fetal hearts and those with cardiac abnormalities. J Ultrasound Med. (2018) 37(5):1159–71. doi: 10.1002/jum.14454
149. Erickson CT, Levy PT, Craft M, Li L, Danford DA, Kutty S. Maturational patterns in right ventricular strain mechanics from the fetus to the young infant. Early Hum Dev. (2019) 129:23–32. doi: 10.1016/j.earlhumdev.2018.12.015
150. Hayek C, Rajagopalan V, Meouchy J, Votava-Smith J, Miller D, del Castillo S, et al. Ventricular and total brain volumes in infants with congenital heart disease: a longitudinal study. J Perinatol. (2020) 40(9):1383–8. doi: 10.1038/s41372-020-0711-4
151. Varcoe TJ, Darby JRT, Holman SL, Bradshaw EL, Kuchel T, Vaughan L, et al. Fetal cardiovascular response to acute hypoxia during maternal anesthesia. Physiol Rep. (2020) 8(3):e14365. doi: 10.14814/phy2.14365
152. Schrauben EM, Darby JRT, Saini BS, Holman SL, Lock MC, Perumal SR, et al. Technique for comprehensive fetal hepatic blood flow assessment in sheep using 4D flow MRI. J Physiol. (2020) 598(17):3555–67. doi: 10.1113/JP279631
153. Lock MC, Darby JRT, Soo JY, Brooks DA, Perumal SR, Selvanayagam JB, et al. Differential response to injury in fetal and adolescent sheep hearts in the immediate post-myocardial infarction period. Front Physiol. (2019) 10:208. doi: 10.3389/fphys.2019.00208
154. Saini BS, Darby JRT, Portnoy S, Sun L, Amerom J, Lock MC, et al. Normal human and sheep fetal vessel oxygen saturations by T2 magnetic resonance imaging. J Physiol. (2020) 598(15):3259–81. doi: 10.1113/JP279725
155. Goncalves LF, Lindblade CL, Cornejo P, Patel MC, McLaughlin ES, Bardo DME. Contribution of fetal magnetic resonance imaging in fetuses with congenital heart disease. Pediatr Radiol. (2022) 52(3):513–26. doi: 10.1007/s00247-021-05234-1
156. Helle-Valle T, Crosby J, Edvardsen T, Lyseggen E, Amundsen BH, Smith HJ, et al. New noninvasive method for assessment of left ventricular rotation: speckle tracking echocardiography. Circulation. (2005) 112(20):3149–56. doi: 10.1161/CIRCULATIONAHA.104.531558
157. Markl M, Frydrychowicz A, Kozerke S, Hope M, Wieben O. 4D Flow MRI. J Magn Reson Imaging. (2012) 36(5):1015–36. doi: 10.1002/jmri.23632
158. Schrauben EM, Saini BS, Darby JRT, Soo JY, Lock MC, Stirrat E, et al. Fetal hemodynamics and cardiac streaming assessed by 4D flow cardiovascular magnetic resonance in fetal sheep. J Cardiovasc Magn Reson. (2019) 21:8. doi: 10.1186/s12968-018-0512-5
159. Kuklisova-Murgasova M, Quaghebeur G, Rutherford MA, Hajnal JV, Schnabel JA. Reconstruction of fetal brain MRI with intensity matching and complete outlier removal. Med Image Anal. (2012) 16(8):1550–64. doi: 10.1016/j.media.2012.07.004
160. Kainz B, Steinberger M, Wein W, Kuklisova-Murgasova M, Malamateniou C, Keraudren K, et al. Fast volume reconstruction from motion corrupted stacks of 2D slices. IEEE Trans Med Imaging. (2015) 34(9):1901–13. doi: 10.1109/TMI.2015.2415453
161. Sethi N, Gai J, Bost J, Donofrio MT. Alterations in cardiac output in fetuses with congenital heart disease. Prenat Diagn. (2022) 42(9):1133–41. doi: 10.1002/pd.6193
162. Pai VM, Axel L. Advances in MRI tagging techniques for determining regional myocardial strain. Curr Cardiol Rep. (2006) 8(1):53–8. doi: 10.1007/s11886-006-0011-4
163. Amzulescu MS, De Craene M, Langet H, Pasquet A, Vancraeynest D, Pouleur AC, et al. Myocardial strain imaging: review of general principles, validation, and sources of discrepancies. Eu Heart J—Cardiovasc Imaging. (2019) 20(6):605–19. doi: 10.1093/ehjci/jez041
164. Young AA, Axel L, Dougherty L, Bogen DK, Parenteau CS. Validation of tagging with MR imaging to estimate material deformation. Radiology. (1993) 188(1):101–8. doi: 10.1148/radiology.188.1.8511281
165. Garot J, Bluemke DA, Osman NF, Rochitte CE, McVeigh ER, Zerhouni EA, et al. Fast determination of regional myocardial strain fields from tagged cardiac images using harmonic phase MRI. Circulation. (2000) 101(9):981–8. doi: 10.1161/01.CIR.101.9.981
166. Yeon SB, Reichek N, Tallant BA, Lima JAC, Calhoun LP, Clark NR, et al. Validation of in vivo myocardial strain measurement by magnetic resonance tagging with sonomicrometry. J Am Coll Cardiol. (2001) 38(2):555–61. doi: 10.1016/S0735-1097(01)01397-3
167. Lima JAC, Jeremy R, Guier W, Bouton S, Zerhouni EA, McVeigh E, et al. Accurate systolic wall thickening by nuclear magnetic resonance imaging with tissue tagging: correlation with sonomicrometers in normal and ischemic myocardium. J Am Coll Cardiol. (1993) 21(7):1741–51. doi: 10.1016/0735-1097(93)90397-J
168. Thomas D, Ferrari VA, Janik M, Kim DH, Pickup S, Glickson JD, et al. Quantitative assessment of regional myocardial function in a rat model of myocardial infarction using tagged MRI. MAGMA. (2004) 17(3–6):179–87. doi: 10.1007/s10334-004-0051-y
169. Liu W, Chen J, Ji S, Allen JS, Bayly PV, Wickline SA, et al. Harmonic phase MR tagging for direct quantification of lagrangian strain in rat hearts after myocardial infarction. Magn Reson Med. (2004) 52(6):1282–90. doi: 10.1002/mrm.20276
170. McVeigh ER, Zerhouni EA. Noninvasive measurement of transmural gradients in myocardial strain with MR imaging. Radiology. (1991) 180(3):677–83. doi: 10.1148/radiology.180.3.1871278
171. Zhou R, Pickup S, Glickson JD, Scott CH, Ferrari VA. Assessment of global and regional myocardial function in the mouse using cine and tagged MRI. Magn Reson Med. (2003) 49(4):760–4. doi: 10.1002/mrm.10423
172. Azhari H, Weiss JL, Rogers WJ, Siu CO, Shapiro EP. A noninvasive comparative study of myocardial strains in ischemic canine hearts using tagged MRI in 3-D. Am J Physiol. (1995) 268(5):H1918–26. doi: 10.1152/ajpheart.1995.268.5.H1918
173. Pedrizzetti G, Claus P, Kilner PJ, Nagel E. Principles of cardiovascular magnetic resonance feature tracking and echocardiographic speckle tracking for informed clinical use. J Cardiovasc Magn Reson. (2016) 18(1):51. doi: 10.1186/s12968-016-0269-7
174. Claus P, Omar AMS, Pedrizzetti G, Sengupta PP, Nagel E. Tissue tracking technology for assessing cardiac mechanics. JACC Cardiovasc Imaging. (2015) 8(12):1444–60. doi: 10.1016/j.jcmg.2015.11.001
175. Hor KN, Gottliebson WM, Carson C, Wash E, Cnota J, Fleck R, et al. Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis. JACC Cardiovasc Imaging. (2010) 3(2):144–51. doi: 10.1016/j.jcmg.2009.11.006
176. Harrild DM, Han Y, Geva T, Zhou J, Marcus E, Powell AJ. Comparison of cardiac MRI tissue tracking and myocardial tagging for assessment of regional ventricular strain. Int J Cardiovasc Imaging. (2012) 28(8):2009–18. doi: 10.1007/s10554-012-0035-3
177. Augustine D, Lewandowski AJ, Lazdam M, Rai A, Francis J, Myerson S, et al. Global and regional left ventricular myocardial deformation measures by magnetic resonance feature tracking in healthy volunteers: comparison with tagging and relevance of gender. J Cardiovasc Magn Reson. (2013) 15(1):8. doi: 10.1186/1532-429X-15-8
178. Wu L, Germans T, Güçlü A, Heymans MW, Allaart CP, van Rossum AC. Feature tracking compared with tissue tagging measurements of segmental strain by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. (2014) 16(1):10. doi: 10.1186/1532-429X-16-10
179. Moody WE, Taylor RJ, Edwards NC, Chue CD, Umar F, Taylor TJ, et al. Comparison of magnetic resonance feature tracking for systolic and diastolic strain and strain rate calculation with spatial modulation of magnetization imaging analysis. J Magn Reson Imaging. (2015) 41(4):1000–12. doi: 10.1002/jmri.24623
Keywords: fetal cardiac function, echocardiography, magnetic resonance imaging, speckle tracking, strain
Citation: Kühle H, Cho SKS, Barber N, Goolaub DS, Darby JRT, Morrison JL, Haller C, Sun L and Seed M (2023) Advanced imaging of fetal cardiac function. Front. Cardiovasc. Med. 10:1206138. doi: 10.3389/fcvm.2023.1206138
Received: 14 April 2023; Accepted: 9 May 2023;
Published: 23 May 2023.
Edited by:
Inga Voges, University Medical Center Schleswig-Holstein, GermanyReviewed by:
Arno A. W. Roest, Leiden University Medical Center (LUMC), NetherlandsTiina Hannele Ojala, Helsinki University Central Hospital, Finland
© 2023 Kühle, Cho, Barber, Goolaub, Darby, Morrison, Haller, Sun and Seed. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mike Seed bWlrZS5zZWVkQHNpY2traWRzLmNh Liqun Sun bGlxdW4uc3VuQHNpY2traWRzLmNh